NDC00140-0071-14: CHLORDIAZEPOXIDE AND AMITRIPTYLI.
CHLORDIAZEPOXIDE AND AMITRIPTYLI. Key specifications include administration: ORAL, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 500.000 TABLETS, active_medicament_medicinal_strength: 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-068-3545, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 500.000 TABLETS |
| active_medicament_medicinal_strength | 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT |
| NSN | 6505-01-068-3545 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT |